This study is looking at a new imaging method called PyL PET/CT for men with prostate cancer. The goal is to see if PyL PET/CT can find cancer spread (metastases) that standard imaging tests might miss. Researchers believe PyL PET/CT could give a clearer picture of where the cancer is. You might be able to join if you are a man aged 18 or older with confirmed prostate cancer and either have high-risk prostate cancer (based on PSA levels, Gleason score, or tumor stage) or your prostate cancer has returned after treatment (biochemical relapse). The study will measure how well PyL PET/CT detects these unsuspected metastases within four weeks.

Study design

This is an interventional study planning to enroll 184 participants. It is designed to assess the clinical value of PyL PET/CT in two groups of prostate cancer patients.

What's involved

You would receive a PyL PET/CT scan. If the scan shows areas of concern not seen on standard imaging, a biopsy might be performed to confirm if it's cancer.

Compensation

Not stated in the trial record.

Follow-up

The primary outcomes, detection of unsuspected metastases, will be measured up to 4 weeks after the scan.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.